← Rocket Lab USA overview

Rocket Lab USA vs The Boeing: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Rocket Lab USA Inc. (RKLB)

Q3 2026
▲2▼2

Neutron Delay and Margin Miss Weigh on Rocket Lab

  • Record Q2 Revenue and Backlog Q2 revenue hit a record $234M, up 62% from a year ago, with a $2.36B backlog. Big Space Force wins (~$700M) and a $266M suborbital contract boosted future work.

    Shows strong demand and financial growth, a key positive for the stock.

  • Iridium Acquisition Clears Antitrust The $8B Iridium deal cleared antitrust review and adds 2.55M subscribers, expanding Rocket Lab's space services. But it also brought heavy dilution: 29.3M shares and $1.94B raised.

    Major strategic move that transforms the company, with both benefits and costs.

  • Neutron First Launch Delayed Neutron's first launch slipped to late 2026 or 2027 after a tank failure. A full-duration engine test passed, but the delay pushes back a key growth driver.

    Neutron is central to Rocket Lab's future, so delay is a major negative.

  • Margin Miss and Governance Risks Q3 gross margin guidance of 29–31% badly missed, sending shares down 9%. Adjusted EBITDA losses persist, and CEO Peter Beck's 5M-share sale, a securities class action, and Iridium deal-fairness probes add risk.

    Directly hit investor confidence and stock price, with ongoing overhangs.

August 2026
▲2▼2

Rocket Lab's record revenue and contracts offset by Neutron delay and margin miss

  • Record Q2 revenue and backlog Rocket Lab reported record Q2 revenue of $234 million, up 62% year over year, and a backlog of $2.36 billion, showing strong demand for its launch and space systems services.

    This is a key new financial milestone that demonstrates the company's growth trajectory.

  • Major Space Force wins and Iridium deal clears antitrust Rocket Lab won about $700 million in Space Force contracts and a record $266 million suborbital contract, while its $8 billion acquisition of Iridium cleared antitrust review, adding recurring revenue and scale.

    These are significant new contract awards and a regulatory milestone that expand the business.

  • Neutron first launch delayed after tank failure Neutron's first launch has slipped to late 2026 or possibly 2027 after a tank failure, delaying a key growth catalyst and raising execution concerns.

    This is a new setback that affects the timeline for a major future revenue driver.

  • Q3 gross margin guidance misses, shares fall 9% Q3 gross margin guidance of 29–31% badly missed expectations, causing shares to fall 9%, while adjusted EBITDA losses continue and the Iridium deal requires heavy debt and stock financing, keeping the stock volatile.

    This is a new negative development that directly impacted investor sentiment and the stock price.

Latest
▲4

Rocket Lab's Iridium Deal, Defense Wins, and Synspective Demand Drive Upside

  • Iridium acquisition adds recurring revenue and scale Rocket Lab agreed to buy Iridium for $8 billion, gaining 2.55 million subscribers and steady cash flow. The stock jumped 24% on the news. This makes Rocket Lab a broader space company, not just a launch provider, which supports a higher value.

    The Iridium deal is the biggest new event this period and directly changes Rocket Lab's business and stock story.

  • Record-fast Space Force mission proves rapid launch capability Rocket Lab completed the VICTUS HAZE mission for the Space Force in record time, launching just 16 hours after notice. This shows its ability to respond quickly for defense customers, which can lead to more government contracts and revenue.

    This new mission success demonstrates a unique capability that could drive future defense demand.

  • SpaceX IPO sell-off creates buying opportunity A sell-off in space stocks after the SpaceX IPO made Rocket Lab shares cheaper despite strong revenue growth and a large backlog. Analysts see this as a sentiment-driven dip, not a fundamental problem, which could attract buyers and lift the stock.

    This explains a recent price drop and why it may reverse, directly addressing the stock's movement.

  • Synspective launches and new 20-mission contract boost demand Rocket Lab completed two Electron launches for Synspective and signed a multiyear deal for 20 more, its largest commercial Electron contract. This adds to its launch backlog and shows growing demand for its small rockets, supporting future revenue.

    This new contract and successful launches directly increase Rocket Lab's backlog and demonstrate commercial demand.

September 2026
▲2▼1

Rocket Lab expands defense, funds Iridium, but dilution and Neutron risks weigh

  • Defense contract wins and backlog growth Rocket Lab won a Space Force prime spot, a Viasat satellite award, and $456 million in new hypersonic and suborbital contracts, lifting backlog 137% to $2.36 billion. This shows strong demand for its defense and space services.

    These new contracts are a key positive driver for the stock, indicating growing demand and future revenue.

  • Iridium acquisition fully funded Rocket Lab fully funded its $8 billion Iridium acquisition, adding 2.55 million subscribers and roughly doubling revenue. This transforms the company's scale and recurring revenue base.

    Completing the funding for this major acquisition is a significant positive event that reshapes the company's financial profile.

  • Heavy share dilution from Iridium deal The Iridium deal required heavy share dilution (29.3 million shares plus $1.94 billion raised), shrinking investor ownership. This dilutes existing shareholders and can pressure the stock price.

    Dilution is a direct negative for current shareholders and a key counterweight to the acquisition's benefits.

  • Neutron launch window narrows, SpaceX rideshare halt helps Neutron's end-of-2026 launch window is narrowing, but SpaceX's Falcon 9 rideshare halt benefits Neutron. Analysts initiated coverage with $80–$122 targets, reflecting mixed sentiment.

    This captures both the ongoing risk of Neutron delays and the competitive opportunity from SpaceX's move, plus analyst attention.

▲4

Rocket Lab Advances Iridium Deal, Wins Defense Work, Neutron Nears

  • Iridium acquisition fully financed and heads to shareholder vote Rocket Lab raised $1.94 billion via share sales to fund its $8 billion Iridium purchase, replacing a $3.6 billion bridge loan and cutting debt needs. Iridium shareholders vote on September 24. The deal adds Iridium's satellite network and 2.55 million subscribers, roughly doubling revenue, but the extra shares dilute existing investors.

    This is the biggest event of the period, directly affecting Rocket Lab's capital structure and future revenue.

  • New defense contracts add $456 million to backlog Rocket Lab won a $190 million award for 20 HASTE hypersonic test flights and a $266 million Space Force contract for at least 12 suborbital missions. These add to its backlog and show growing government demand for its launch services, supporting future revenue and the stock.

    These new contracts are concrete evidence of expanding defense demand, a key growth driver.

  • SpaceX halts Falcon 9 rideshare, opening door for Neutron SpaceX stopped taking new Falcon 9 rideshare reservations, betting Starship will fill the gap. Rocket Lab's Neutron rocket targets the same medium-lift market. With backlog up 137% to $2.36 billion and 90+ launches under contract, Rocket Lab is the most direct beneficiary, though Neutron's end-of-2026 launch window is narrowing.

    This is a major competitive shift that could hand Rocket Lab a larger share of the launch market.

  • Analyst coverage starts with high price targets Raymond James initiated coverage with an $80 target and Cantor Fitzgerald reiterated a $122 target, both citing Neutron's first launch and the Iridium deal as catalysts. These ratings can boost investor confidence and attract new buyers, pushing the stock up.

    Analyst ratings influence investor sentiment and can drive short-term price moves.

▲2

Rocket Lab Wins Defense Work, Funds Iridium, But Neutron Slips

  • Defense demand expands with new Space Force and Viasat awards Rocket Lab won a prime spot on a nearly $1 billion Space Force program and was picked by Viasat to build a secure military satellite. These add to its backlog and show government demand for its launch and satellite work, supporting future revenue and the stock.

    New defense contracts directly increase Rocket Lab's future revenue pipeline.

  • New solar cell and component sales widen its product lineup Rocket Lab released a lighter, germanium-free solar cell and is selling avionics, radios and batteries used on over 1,800 missions. These products open new markets beyond launch, adding revenue streams that can grow with satellite demand and support the stock.

    New products expand Rocket Lab's addressable market and revenue sources.

  • Iridium acquisition fully funded, but with heavy share dilution Rocket Lab fully financed its $8 billion Iridium purchase by issuing 29.3 million shares, removing deal uncertainty but diluting existing shareholders. The deal adds Iridium's revenue and cash flow, yet the extra shares mean each investor owns a smaller slice, weighing on the stock.

    Financing removes a major risk but the dilution is a real counterweight for shareholders.

▲3▼1

Rocket Lab's Contract Wins and Iridium Progress Offset Neutron Delay

  • Record $266M Space Force suborbital launch contract Rocket Lab won its largest launch contract ever: about $266 million from the U.S. Space Force for roughly a dozen suborbital launches, with the first expected by end-2026. This adds to its backlog and proves government demand for its HASTE program, supporting future revenue and the stock.

    This is a new, large contract win that directly boosts Rocket Lab's backlog and revenue outlook.

  • Iridium acquisition clears US antitrust review and financing arranged The Hart-Scott-Rodino waiting period expired, clearing US antitrust review for the $8 billion Iridium deal. Rocket Lab has a $3.6 billion bridge loan and can sell up to $1.94 billion of stock. This reduces deal uncertainty and moves the strategic expansion forward, supporting the stock.

    This is a new regulatory milestone that de-risks the Iridium acquisition, a major strategic move.

  • Space Force consortium wins and $12M orders for secure satellite network Rocket Lab joined the Space Force's Space Data Network Consortium and won two $12 million orders to demonstrate secure optical communications. This positions it in a key military satellite network program, potentially leading to more defense work and revenue, supporting the stock.

    This is a new contract win and consortium membership that expands Rocket Lab's defense business.

  • Neutron first launch may slip to 2027 Rocket Lab's Neutron rocket timeline softened, with an analyst noting the first launch could be pushed to 2027. Neutron is key to competing for larger launch contracts, so further delay keeps a major growth catalyst on hold and pressures the stock.

    This is a new update on the Neutron timeline that affects a critical future growth driver.

▲3▼1

Record Revenue and Backlog, but Margin Miss and Iridium Deal Weigh

  • Record Q2 revenue and backlog Rocket Lab reported record second-quarter revenue of $234 million, up 62% from a year ago, and a record backlog of $2.36 billion, up 137%. It guided next quarter to another record. This shows the business is growing fast and winning more work, which supports the stock.

    This is the core new financial result that shows the company's growth and supports the stock.

  • Weak margin guidance and continued losses Despite record revenue, Rocket Lab guided third-quarter gross margin to 29%-31%, far below the roughly 37.6% analysts expected, and still expects an adjusted EBITDA loss of $17-$23 million. Investors focused on this, sending shares down 9% on August 11. Lower profitability than hoped pressures the stock.

    This is the main counterweight that explains why the stock fell despite record revenue.

  • Iridium acquisition agreement Rocket Lab agreed to acquire Iridium Communications for about $54 per share, aiming to combine Iridium's satellite network with its launch and manufacturing. The deal would expand Rocket Lab beyond launch into satellite services, a strategic growth move, though it still needs approvals and is expected to close mid-2027.

    This is a major new strategic move that could reshape the company and drive long-term value.

  • New launch contracts and acquisitions Rocket Lab signed over $437 million in new launch contracts in Q2 and after, pushing its launch backlog past 90 missions. It also closed the acquisitions of Mynaric and Motiv and introduced its GHOST launch system. These expand its offerings and future revenue, supporting the stock.

    These new contracts and acquisitions show growing demand and expanded capabilities, supporting future revenue.

▲3▼1

Rocket Lab Wins Big Space Force Deals, But Neutron Delay and Iridium Financing Weigh

  • Two major Space Force contract wins add nearly $700M to backlog Rocket Lab won a $397 million Space Force contract to build, launch and operate Flatellite satellites, plus a $266 million award for 12 suborbital launches. These add to its $2.2 billion backlog and show government demand for its full range of services, supporting future revenue and the stock.

    These are the largest new contract wins this period and directly boost future revenue and backlog.

  • Rapid-response mission proves Rocket Lab can do more than launch Rocket Lab completed the Victus Haze mission for the Space Force, supplying the rocket, spacecraft and on-orbit operations in one contract. This shows it can earn more revenue per customer and win repeat orders, though the contract is small versus its backlog.

    It demonstrates a new integrated capability that could lift future revenue per mission.

  • SpaceX launch capacity crunch leaves room for Rocket Lab SpaceX is using most Falcon 9 launches for its own Starlink network, with commercial capacity sold out until 2028 or 2029. This pushes satellite operators toward alternatives like Rocket Lab's upcoming Neutron rocket, strengthening its competitive position and long-term demand.

    It explains a key external force that could drive customers to Rocket Lab.

  • Neutron delay and Iridium financing still weigh on the stock Neutron's first launch slipped to later 2026 after a tank failure, and the $8 billion Iridium acquisition needs heavy debt and stock financing. Until Neutron flies and the deal closes, these overhangs keep the stock volatile and below analyst targets, even as contracts roll in.

    It is the main counterweight to the positive contract news and explains why the stock remains depressed.

July 2026
▲2▼1

Rocket Lab advances on Neutron, contracts, but insider sale and legal risks weigh

  • Neutron rocket progress Rocket Lab's Neutron rocket passed a full-duration engine test and revealed a reusable fairing, key milestones for its next-generation vehicle. Analysts also highlighted Rocket Lab as a top SpaceX alternative with a $2.2B backlog.

    Neutron progress and analyst endorsement are positive operational and sentiment drivers.

  • New government contracts Rocket Lab won a spot in the $5.6B Space Force NSSL Phase 3 Lane 1 program and a $266M Air Force suborbital contract, expanding its government business. It also completed two NASA Mars Escapade spacecraft and expanded launch infrastructure.

    Contract wins and NASA milestones are new positive business developments.

  • CEO share sale and legal issues CEO Peter Beck sold 5 million shares, dropping the stock 10.4%. A securities class action over Neutron timeline disclosures and a $3B equity offering threaten dilution, while a law firm probes the Iridium deal's fairness.

    Insider selling and legal/dilution risks are major negative pressures on the stock.

  • Iridium acquisition update Iridium, Rocket Lab's acquisition target, posted 4% revenue growth, but shares fell nearly 20% after the deal announcement and a law firm is investigating the deal's fairness.

    Iridium's growth is positive, but the stock drop and investigation create mixed signals.

▲4

Rocket Lab Wins $456M in New Contracts, Advances NASA Mars Mission

  • Rocket Lab wins $266M U.S. Air Force contract for 12 suborbital launches The U.S. Air Force awarded Rocket Lab a $266 million contract for 12 suborbital launches by 2028. This adds to the backlog and shows growing demand for its HASTE program, supporting future revenue and lifting the stock.

    This is a new, material contract win that directly boosts Rocket Lab's backlog and revenue outlook.

  • Rocket Lab completes two spacecraft for NASA Mars mission Rocket Lab finished two spacecraft for NASA's Escapade mission to Mars, set for October launch. This proves its spacecraft-building capability, which could lead to more NASA and commercial contracts, supporting the stock.

    This milestone demonstrates execution on a high-profile NASA mission, potentially unlocking future contracts.

  • Rocket Lab expands launch infrastructure for more frequent missions Rocket Lab is adding ground systems, mission control, and launch sites to handle more launches for commercial and national security customers. This capacity expansion positions it to capture growing demand and scale revenue.

    Infrastructure investment signals confidence in future demand and supports higher launch cadence.

  • Iridium reports revenue growth and completes Aireon acquisition Iridium, which Rocket Lab is acquiring, reported 4% revenue growth and completed its Aireon purchase, adding $100M in annual service revenue. This strengthens the strategic case for the deal, though it still awaits approval.

    Positive developments at Iridium support the rationale for Rocket Lab's pending acquisition, reducing uncertainty.

▲3▼1

Neutron Progress and Space Force Win Boost Rocket Lab, but Iridium Deal Fallout Weighs

  • Neutron engine test and new fairing design Rocket Lab completed a full-duration second-stage engine test for its Neutron rocket and revealed a reusable 'Hungry Hippo' fairing. These advances support the case for a working medium-lift rocket, which could unlock bigger defense and constellation launches, lifting the stock.

    This is a new technology milestone that directly addresses the key uncertainty around Neutron's timeline.

  • Selected for $5.6B Space Force launch program Rocket Lab won a spot in the Space Force's National Security Space Launch Phase 3 Lane 1 program, worth up to $5.6 billion. It can't win task orders until Neutron flies, but the selection opens a huge government market and supports future revenue.

    This is a new contract win that expands Rocket Lab's addressable defense market.

  • Iridium deal fairness investigation and stock decline A law firm is investigating whether Iridium's board acted fairly in selling to Rocket Lab. Since the deal was announced, Rocket Lab shares have fallen nearly 20%, and the probe adds uncertainty about the acquisition's terms and integration, pressuring the stock.

    This is a new legal development that adds a real counterweight to the bullish news.

  • Record first-half performance and analyst optimism Rocket Lab stock rose 46% in the first half on record revenue, 106% backlog growth, and more launches sold in Q1 than all of last year. Analysts remain bullish with an average target of $117, though the stock has pulled back recently.

    This summarizes the strong fundamental momentum that continues to attract investors.

▼2▲1

Rocket Lab's Iridium Deal and Neutron Hopes Face Insider Selling and Legal Risks

  • Rocket Lab seen as top SpaceX alternative with $2.2B backlog Analysts and media highlight Rocket Lab as a more reasonably valued way to invest in space, noting its record launch contract and backlog over $2.2 billion. This draws investor attention and money away from SpaceX, supporting demand for RKLB shares.

    This explains why investors are choosing Rocket Lab over SpaceX, a key force behind the stock's appeal.

  • CEO sells 5 million shares, stock drops 10.4% CEO Peter Beck sold 5 million shares under a pre-arranged plan, causing a sharp 10.4% drop. While the sale was planned, it spooked investors and added selling pressure, especially after the stock had run up on the Iridium news.

    This is a major negative event that directly hit the stock price and investor sentiment this period.

  • Legal and financing overhangs: class action and $3B equity offering A securities class action filed July 1 over Neutron timeline disclosures and a $3 billion at-the-market equity offering announced June 24 create near-term risks. These can dilute shares and weigh on the stock until resolved.

    These are new negative factors that could pressure the stock and are not yet fully priced in.

Q2 2026
▲3▼1

Rocket Lab rides Nasdaq-100 inclusion, Iridium deal, and record launch cadence

  • Nasdaq-100 inclusion Joining the Nasdaq-100 index on June 22 forced index-tracking funds to buy RKLB shares, creating steady demand and lifting the stock.

    Index inclusion is a major new demand catalyst for the stock.

  • Iridium acquisition transforms company Rocket Lab agreed to buy Iridium for $8 billion at a 24% premium, turning it into a full-service space company and sending shares up about 16%.

    The transformative acquisition is the biggest new strategic event of the period.

  • Record launch cadence and repeat demand NASA booked three Electron launches, a tenth straight Synspective launch was confirmed with 17 more booked, and a record 16h42m Space Force turnaround showed operational strength.

    These operational wins demonstrate growing demand and execution capability.

  • SpaceX IPO and Starfall test pressure SpaceX's IPO siphoned investor attention and capital from small space stocks, while its successful Starfall reentry pod test beat Rocket Lab's in-development system.

    This is the main competitive and capital headwind facing Rocket Lab.

June 2026
▲3▼1

Rocket Lab rides Nasdaq-100 inclusion, Iridium deal, and record launch cadence

  • Nasdaq-100 inclusion Joining the Nasdaq-100 index on June 22 forced index-tracking funds to buy RKLB shares, creating steady demand and lifting the stock.

    Index inclusion is a major new demand catalyst for the stock.

  • Iridium acquisition transforms company Rocket Lab agreed to buy Iridium for $8 billion at a 24% premium, turning it into a full-service space company and sending shares up about 16%.

    The transformative acquisition is the biggest new strategic event of the period.

  • Record launch cadence and repeat demand NASA booked three Electron launches, a tenth straight Synspective launch was confirmed with 17 more booked, and a record 16h42m Space Force turnaround showed operational strength.

    These operational wins demonstrate growing demand and execution capability.

  • SpaceX IPO and Starfall test pressure SpaceX's IPO siphoned investor attention and capital from small space stocks, while its successful Starfall reentry pod test beat Rocket Lab's in-development system.

    This is the main competitive and capital headwind facing Rocket Lab.

▲2▼1

Rocket Lab's $8B Iridium Deal Reshapes Space Sector

  • Rocket Lab to acquire Iridium for $8 billion Rocket Lab agreed to buy Iridium Communications for $54 per share in cash and stock, a 24% premium. This transforms Rocket Lab from a launch provider into a full-service space company with its own satellite network and customers. The stock jumped about 16% on the news.

    This is the single biggest new event of the period and directly explains the stock's sharp move.

  • Space sector rally lifts peers after deal The Iridium deal sparked a broad rally in space stocks, with Planet Labs and Viasat surging on speculation of more consolidation. This shows investors see space assets as valuable strategic infrastructure, which can lift Rocket Lab's whole sector and its own valuation.

    It shows the deal's ripple effect and renewed investor interest in the space sector, which supports RKLB's price.

  • SpaceX's Starfall reentry pod tests successfully SpaceX successfully tested a reentry cargo pod, giving it a lead over Rocket Lab, whose own reentry system is still in development. This is a competitive threat in the emerging market for returning cargo from space, which could limit Rocket Lab's future growth in that area.

    It is a new competitive development that could weigh on Rocket Lab's long-term prospects.

  • Iridium valuation debate adds integration risk Analysts note Iridium may be undervalued on cash flow but expensive on earnings, and the pending acquisition adds complexity. While the deal is expected to close in mid-2027, integration risks and the premium paid could pressure Rocket Lab if the combined company doesn't deliver expected benefits.

    It provides a fair counterweight, highlighting that the deal is not without risks and could affect RKLB's stock if integration stumbles.

▲3

Rocket Lab wins NASA and defense deals, but SpaceX IPO still weighs on shares

  • NASA books three Electron launches NASA picked Rocket Lab for three dedicated Electron launches for the PolSIR and TSIS-2 science missions starting early 2027. New government contracts add to the backlog and show customers keep choosing Electron, supporting future revenue and the stock.

    A fresh contract win that adds demand and backlog, directly supporting the bull case.

  • Record 17-hour Space Force launch turnaround Rocket Lab launched the Space Force VICTUS HAZE mission just 16 hours 42 minutes after notice, beating the old record by over 10 hours. It proves the company can respond fast to military needs, strengthening its case for more defense work.

    A new operational milestone that boosts Rocket Lab's credibility for national security contracts.

  • Tenth straight Synspective launch, 17 more booked Rocket Lab placed another satellite for Japan's Synspective, its tenth dedicated launch for them with 100% success. Seventeen more missions are already booked, showing repeat customers and steady launch demand that supports revenue growth.

    New evidence of recurring customer demand and launch reliability, key to the growth story.

▲3▼1

Rocket Lab joins Nasdaq-100, buys Motiv, but SpaceX IPO pulls small space stocks down

  • Nasdaq-100 inclusion Rocket Lab will join the Nasdaq-100 index on June 22, which typically forces index-tracking funds to buy the stock. This new demand can push the share price up, and it also raises the company's profile among big investors.

    This is a major new event that directly increases demand for RKLB shares.

  • Motiv Space Systems acquisition Rocket Lab acquired Motiv Space Systems, adding robotic arms and precision parts used on NASA's Perseverance rover. This expands its space systems business, making the company less dependent on launches and more valuable as a full-service space company.

    This new acquisition strengthens Rocket Lab's technology and revenue mix, supporting a higher valuation.

  • SpaceX IPO shifts investor attention SpaceX's huge IPO has pulled investor money and attention away from smaller space stocks. Rocket Lab fell about 5% as investors chose SpaceX instead, and this competition for investor dollars could keep pressuring the stock.

    This is a new competitive force that directly hurt RKLB's stock price and sentiment.

  • Strong Q1 revenue growth and analyst targets Rocket Lab reported 63.5% revenue growth, beating estimates, and analysts raised price targets to $129 and even a bull case of $150. Strong financial results and optimistic forecasts can attract buyers and lift the stock.

    This new earnings beat and analyst upgrades provide fundamental support for the stock price.

The Boeing Company (BA)

Q3 2026
▲3▼1

Boeing's recovery gains traction, but certification and production risks persist

  • China reopens with freighter order China Southern ordered $3.6 billion of Boeing freighters, signaling China's return after a long freeze. This could revive Boeing's commercial sales in a key market and supports the stock.

    It's a major new commercial win that shows improving demand from China.

  • FAA restores certification authority and certifies MAX 7 The FAA gave Boeing back the power to certify its own planes and approved the MAX 7. This speeds up deliveries and reduces regulatory friction, a positive for future revenue.

    It removes a key regulatory hurdle and enables faster deliveries.

  • Free cash flow turns positive Boeing generated $631 million in free cash flow, ending six quarters of cash burn. This shows the company is stabilizing financially, which is crucial for its recovery and stock price.

    It marks a major financial milestone after a long period of losses.

  • 777X and MAX 10 certification delays The 777X is now expected in the late 2020s, and the MAX 10 was delayed by a software glitch. These push back future revenue and raise doubts about Boeing's ability to deliver new models on time.

    It highlights ongoing certification problems that threaten future growth.

September 2026
▲2▼2

Boeing's Cash Turns Positive, But Production and Certification Woes Persist

  • Free Cash Flow Turns Positive Boeing generated $631 million in free cash flow, ending six quarters of cash burn. This is a key sign that the company's turnaround is gaining traction and reduces the need for new borrowing.

    This is a major positive development that shows Boeing's financial health improving, directly impacting investor confidence.

  • Engineers Approve Contract, Averting Strike Engineers approved a four-year contract, avoiding a strike that could have halted production. This removes a major risk and allows Boeing to focus on increasing output and certifying new planes.

    The strike was a looming threat from earlier reports; its resolution is new and positive for Boeing's stability.

  • 737 Production Bottlenecks and Guidance Cut The CEO warned that 737 production is not stable at 47 per month due to wing bottlenecks, and Boeing cut its 2026 free-cash-flow guidance to about $2 billion. This raises concerns about execution.

    This is a new negative that directly impacts Boeing's financial outlook and production targets.

  • FAA Delays 737 MAX 10 Certification The FAA delayed certification of the 737 MAX 10 due to a software glitch, pushing back a key revenue source. This adds regulatory uncertainty and could delay deliveries further.

    This is a new regulatory setback that affects Boeing's ability to deliver a major variant and generate revenue.

Latest
▲3▼1

Boeing's MAX 10 certification delayed, but defense wins and strike averted

  • FAA halts 737 MAX 10 certification over software glitch The FAA delayed certification of the 737 MAX 10 after finding a software issue that can disable autopilot during certain landings. This postpones deliveries and cash payments, and the stock fell as much as 6.8% on the news. It also adds uncertainty to Boeing's recovery and its ability to compete with Airbus's A321neo.

    This is a major new regulatory setback that directly delays a key program and pressures the stock.

  • Boeing wins $20 billion Navy F/A-XX fighter contract The U.S. Navy selected Boeing to develop its next-generation carrier-based fighter, the F/A-XX, in a deal worth over $20 billion. This is a concrete defense order that boosts Boeing's long-term revenue and backlog. The stock rose 2.5% after hours on the news, while rival Northrop Grumman fell.

    A large new defense contract win that supports future revenue and investor confidence.

  • Boeing engineers approve four-year contract, averting strike Boeing's largest white-collar union ratified a new four-year contract, removing the threat of a strike that could have disrupted production and certification work. The deal includes a 10% wage increase and annual raises. Shares rose about 4% on the news, as it clears a major labor risk.

    This eliminates a significant near-term risk that had been weighing on the stock.

  • GE9X engine fix keeps 777X on track for 2027 GE Aerospace began shipping GE9X engines with a redesigned mid-seal to Boeing and expects FAA certification within months. This supports the 777X's planned 2027 entry into service, a key widebody program for Boeing's future cash flow. The news reduces uncertainty around the program's timeline.

    It removes a potential delay risk for the 777X, a major future revenue source.

▲2▼2

Boeing's cash turns positive, but production and China hopes stall

  • Free cash flow turns positive after six quarters Boeing generated $631 million in free cash flow last quarter, ending a long stretch of losses. This is a big deal because cash is what pays down debt and funds production. It supports the stock, though the company still carries about $26 billion in net debt.

    This is a new, concrete sign of financial recovery that directly affects Boeing's value.

  • Major order wins: Korean Air, Turkish Airlines, defense contracts Boeing finalized a 103-plane order with Korean Air worth $36.2 billion at list prices, won a commitment for up to 150 737 Max jets from Turkish Airlines, and secured several defense deals including a $562 million Navy contract for MQ-25 refueling drones. These add to Boeing's backlog and future revenue.

    These are new, large orders that directly boost Boeing's future sales and backlog.

  • 737 MAX production ramp slower than expected, cash outlook cut CEO Ortberg said Boeing is struggling to stabilize 737 MAX production at 47 planes per month because of wing-supply problems, and 787 output is also below target. The company cut its 2026 free-cash-flow expectation to about $2 billion from $3 billion. This delays the recovery and pressures the stock.

    This is a new warning that directly lowers Boeing's cash outlook and delays its turnaround.

  • China order hopes fade; Spirit liabilities add $1.9 billion Hopes for a large new China order faded ahead of the Trump-Xi summit, with Boeing only working to finalize a provisional 200-plane deal. Separately, Boeing found $1.9 billion in extra liabilities at Spirit AeroSystems, including loss-making contracts. Both weigh on sentiment and future cash.

    These are new negative developments that reduce expected demand and add hidden costs.

▼3▲1

Boeing's cash and production outlook darkens as defense orders build

  • CEO warns on production and cash flow CEO Ortberg said Boeing isn't stable at its 47-per-month 737 target because wing production is a bottleneck, and free cash flow above $2 billion is now less likely. He also flagged possible defense charges and 787 engine delays. The stock fell 6% as investors saw the recovery taking longer.

    This is the period's biggest negative driver, directly hitting Boeing's cash and production recovery story.

  • August deliveries slip and 777X testing spills into 2027 Boeing delivered 51 commercial jets in August, down from 57 a year earlier, though year-to-date deliveries are still the best since 2018. Separately, the CEO said 777X certification testing will spill into next year, delaying a key widebody program and its future cash.

    Weaker monthly deliveries and a delayed 777X timeline reinforce the production and cash concerns weighing on the stock.

  • Defense order book expands with Saudi and KC-46 deals The U.S. approved a $5.75 billion weapons sale to Saudi Arabia, with Boeing as principal contractor for JDAM-ER kits and bombs. The Air Force also raised Boeing's KC-46 tanker contract ceiling to $19.1 billion from $5.7 billion, adding $13.4 billion for foreign sales through 2035.

    These new defense orders add long-term revenue visibility, a real counterweight to the commercial cash concerns.

  • Fed rate hike pressures aerospace financing and demand The Federal Reserve raised interest rates for the first time in three years, to 3.75–4.00%, and signaled possibly one more hike. Higher rates make borrowing costlier for Boeing and its airline customers, which can slow aircraft orders and raise financing costs, adding pressure on the stock.

    The rate hike is a new macro headwind that affects Boeing's capital costs and customer demand.

August 2026
▲2▼2

Boeing's August: Certification Wins, Defense Surge, But Strike and Safety Risks Loom

  • 737 MAX 7 Certification Unlocks Deliveries The FAA certified the 737 MAX 7, allowing Boeing to start delivering the smallest MAX variant. This opens a new revenue stream and helps Boeing compete in the narrow-body market, especially with airlines seeking smaller jets.

    This is a new positive development that directly enables future sales and deliveries.

  • Defense Wins: $131.2B F-15 Contract and Missile Work Boeing secured a massive $131.2 billion F-15 contract and expanded missile programs, boosting its defense backlog. These long-term deals provide stable revenue and help offset commercial aviation's cyclicality.

    A major new contract that strengthens Boeing's defense segment and future cash flow.

  • Engineers Authorize October Strike About 17,000 Boeing engineers rejected a contract offer and voted to strike in October. A walkout could halt production and delay certification of the MAX 10 and 777X, threatening Boeing's recovery timeline.

    A new labor risk that could disrupt operations and delay key programs.

  • FAA Orders Inspections and Fines Boeing $3.1M The FAA required inspections of 471 MAX jets for fuselage cracks and fined Boeing $3.1 million. This raises safety concerns, may ground some planes temporarily, and adds regulatory pressure on Boeing's quality control.

    A new regulatory and safety issue that could impact deliveries and reputation.

▲2▼2

Boeing's defense wins surge, but strike threat and FAA fine weigh

  • Massive F-15 contract and defense profitability Boeing won a $131.2 billion F-15 contract for production and modernization through 2037, potentially adding over $13 billion a year to its defense unit, which just turned profitable. This huge, long-term order boosts future revenue and supports the stock.

    This is the biggest new contract and directly lifts Boeing's defense outlook.

  • Engineers strike threat disrupts production and certification About 17,000 engineers rejected Boeing's contract and authorized a strike if no deal by October 6. A walkout could stall 737 MAX 10 and 777-9 certifications and slow the 737 production ramp, threatening Boeing's recovery and pressuring the stock.

    This is a new, active risk that could delay key programs and cash flow.

  • FAA fine for safety violations Boeing paid a $3.1 million FAA fine for safety violations tied to the 2024 MAX 9 incident. Although small, it reminds investors that quality and regulatory issues persist, which can weigh on sentiment and future oversight.

    This is a new regulatory penalty that reinforces safety concerns.

  • China trade visit could bring aircraft orders President Xi may bring a large CEO delegation to Washington on September 24, raising hopes for Boeing orders similar to the 2015 deal for 300 jets. A major order would boost demand and cash flow, though it is not yet confirmed.

    This is a new potential demand catalyst that could significantly help Boeing.

▲2▼2

Boeing wins 737-7 approval, defense deals; engineer strike threat looms

  • FAA certifies 737-7, clearing smallest MAX for service The FAA granted Boeing an amended type certificate for the 737-7, the smallest and longest-range MAX variant. Certification removes a major regulatory hurdle, letting Boeing start delivering the jets and turn its backlog into cash, which supports the stock.

    New regulatory approval directly unlocks a revenue stream and reduces uncertainty around the MAX family.

  • Pentagon procurement surge adds defense work The Pentagon is pushing contractors to rapidly scale missile interceptor and munitions production, and Boeing reached framework agreements to boost SM-3 interceptor output. This adds years of visible defense revenue, steadying Boeing while its commercial cash flow recovers.

    New defense framework agreements expand Boeing's long-term revenue pipeline.

  • Engineers union rejects contract, authorizes strike About 17,000 Boeing engineers and technical workers voted down a four-year contract offer and authorized a strike when the contract expires in October. A walkout could delay certification of the 737 MAX 10 and 777X and slow production, threatening Boeing's recovery timeline.

    A potential strike by engineers directly threatens Boeing's certification and production schedule.

  • Airbus A350F freighter nears first test flight Airbus tentatively set the first test flight of its A350F freighter for late September, aiming to enter service in 2027. This intensifies competition in the air cargo market long dominated by Boeing, potentially pressuring future orders for Boeing's freighter lineup.

    A credible Airbus freighter challenger threatens Boeing's dominant cargo-jet franchise.

▲3

Boeing's defense orders surge while it sheds units and keeps delivering jets

  • Pentagon pushes Boeing to speed weapons output The Pentagon told Boeing and other contractors to accelerate weapons production, with plans due by late August, as missile stockpiles run low after the Iran war. Faster, bigger defense orders mean more long-term revenue for Boeing's defense arm, supporting the stock.

    A new, concrete demand signal from Boeing's biggest defense customer.

  • Steady defense contract wins: F/A-18, Apache, SM-3 Boeing won a $109 million Navy order for F/A-18 wing panels, a $636 million Army Apache support modification, and seven-year frameworks to expand SM-3 interceptor output. These add years of visible defense work, steadying revenue while commercial cash flow recovers.

    Several new contract awards show defense demand converting into booked business.

  • July deliveries of 53 jets keep cash coming in Boeing delivered 53 planes in July, led by 39 737 MAX and 10 787s, and booked 43 net orders. Airlines pay most of a jet's price on delivery, so steady deliveries turn backlog into cash and support Boeing's goal of positive free cash flow.

    Monthly delivery data is the clearest read on Boeing's cash-generating recovery.

  • Boeing sells Wisk, Insitu, SkyGrid to Archer for a stake Boeing is handing three subsidiaries — including profitable drone-maker Insitu — to Archer Aviation for about a 20% stake and warrants. It raises some cash and focuses Boeing, but gives up over $200 million of annual revenue and control of its autonomous-aircraft bets.

    A new strategic divestiture that changes Boeing's portfolio and future revenue mix.

▲3▼1

Boeing's MAX 7 certified, deliveries jump, but new FAA crack inspection order hits

  • FAA certifies 737 MAX 7 after years of review The FAA certified the smallest 737 MAX variant, clearing the way for deliveries to Southwest. This unlocks a new revenue stream and shows Boeing can get its planes approved, lifting the stock 8% on the day and improving confidence in future cash flow.

    This is a major new regulatory milestone that directly boosts Boeing's product lineup and future sales.

  • Q2 revenue beats on 14% jump in commercial deliveries Boeing delivered 14% more commercial jets than a year ago, and revenue beat expectations. More deliveries mean more cash coming in, and the company is ramping production toward 57 MAX jets a month, supporting its goal of positive free cash flow this year.

    This shows the core turnaround is gaining speed, a key driver of the stock's recovery story.

  • Boeing jumps over 8% on double upgrade and easing Middle East tensions A double upgrade from analysts and falling oil prices after Iran peace talks lifted Boeing shares. Lower oil helps airline profits, which supports demand for Boeing's planes, while the upgrade signals growing Wall Street confidence in the turnaround.

    This captures a major sentiment shift and external tailwind that pushed the stock sharply higher.

  • FAA orders inspections of 471 737 MAX jets after fuselage cracks found The FAA issued an airworthiness directive requiring inspections of 471 U.S. 737 MAX jets for cracks in a structural part. This adds a new regulatory burden, could slow deliveries, and raises fresh safety concerns, weighing on the stock and reminding investors that quality issues persist.

    This is a new negative regulatory event that could disrupt deliveries and hurt sentiment.

July 2026
▲3▼1

Boeing's recovery gains traction despite 777X and cash hurdles

  • China market reopens with freighter order China Southern ordered $3.6B of freighters, reopening Boeing's Chinese market after a long freeze. This signals renewed demand from a key region and could lead to more orders, supporting future revenue.

    This is a major new positive that directly addresses Boeing's commercial challenges and market access.

  • Production and certification improvements A fourth 737 MAX line started, June deliveries hit 64 jets, and the FAA restored Boeing's certification authority. These steps boost output and streamline approvals, helping Boeing meet demand and improve efficiency.

    These operational and regulatory wins are new and directly support Boeing's production ramp-up and delivery goals.

  • Farnborough orders and positive cash flow At Farnborough, Boeing won orders from SMBC, Riyadh Air, and AerCap, while Q2 free cash flow turned positive at $631M with revenue up 8%. This shows improving demand and financial health.

    New order wins and cash flow improvement are key indicators of Boeing's recovery and financial stability.

  • 777X delays and financial concerns 777X certification slipped toward the late 2020s, and Emirates rejected its first jets as outdated. Q2 loss widened on a $280M Air Force One charge, and Boeing burned $1.5B cash in Q1, trading at 833x forward earnings.

    These setbacks highlight ongoing challenges in certification, customer satisfaction, and profitability that weigh on the stock.

▲2▼2

FAA Restores Boeing Certification Authority; Q2 Cash Turns Positive

  • FAA restores Boeing's certification authority The FAA gave Boeing back the power to issue airworthiness certificates for new 737 MAX and 787 jets after eight months of audits. This removes a costly bottleneck, letting Boeing deliver parked planes faster and turn them into cash, directly supporting its recovery and stock.

    This is a new regulatory milestone that speeds deliveries and cash flow, a key driver for BA.

  • Q2 free cash flow turns positive, revenue up 8% Boeing generated $631 million in free cash flow, far better than the expected outflow, and revenue rose 8% to $24.6 billion. Positive cash flow is the clearest sign the turnaround is working, and management reaffirmed its full-year target, boosting investor confidence.

    This is the first positive free cash flow in years, a major new financial milestone that drove the stock up 6%.

  • Q2 loss wider than expected on Air Force One charge Boeing lost $428 million, or 76 cents per share, worse than the 30-cent loss analysts expected, due to a $280 million charge on the delayed Air Force One jets. This shows fixed-price defense contracts still bleed cash, a real drag on earnings and sentiment.

    This is a new negative earnings surprise that offsets some of the positive cash flow news.

  • FAA proposes 737 MAX seat inspection order The FAA wants mandatory inspections of 453 U.S. 737 MAX jets because some seats may not be properly attached, risking injury in an emergency. While Boeing supports the fix, it adds another regulatory burden and could slow deliveries or raise costs, weighing on the stock.

    This is a new regulatory issue that could disrupt 737 MAX operations and deliveries.

▼3▲1

Farnborough order blitz lifts Boeing, but 777X and cash burn weigh

  • Farnborough order blitz Boeing announced a wave of orders at the Farnborough Airshow: 100 737 MAX from SMBC, 15 787-10 from Philippine Airlines, 28 787s from Riyadh Air, 15 787-9 from AerCap, 5 777-8 freighters from MSC, and 8 jets from Uganda Airlines. These add to Boeing's backlog and show strong demand for its planes, supporting future revenue and cash flow.

    This is the biggest new positive event of the period, directly boosting Boeing's order book and investor confidence.

  • Emirates rejects first 777X jets Emirates refused delivery of its first 10 Boeing 777X jets, calling them outdated and fit only for scrap. This is a major blow to Boeing's newest widebody program, which is already years late. It raises doubts about future 777X sales and delays cash from a key aircraft, pressuring the stock.

    This is a new negative development that directly undermines confidence in Boeing's flagship widebody program.

  • China order doubts resurface China is seeking new guarantees on engine and spare parts supply before proceeding with a proposed 200-plane Boeing order, worth $17–19 billion. This raises doubts about the deal announced after the Trump-Xi summit. If the order stalls, Boeing loses a major expected boost to its backlog and future revenue.

    This is a new negative update on a previously announced order, showing it may not materialize as hoped.

  • Cash burn remains a concern Boeing reported a $1.5 billion free cash flow burn and a negative 6.1% operating margin in its Commercial Airplanes unit. Despite revenue growth and debt repayment, retail investors are focused on the cash burn. Until Boeing generates positive cash flow, the stock may struggle to convince skeptics, even as Wall Street remains bullish.

    This is a new article highlighting a key ongoing financial weakness that weighs on investor sentiment.

▲3▼1

777X delay hits Boeing as deliveries and Max approvals advance

  • 777X certification slips toward late 2020s Fresh regulatory scrutiny threatens to push 777X approval into the late 2020s, and shares fell 6.3% on the news. The 777X is Boeing's newest big widebody, so a longer wait means later cash from a key program and more doubt about whether Boeing can hit its long-term targets.

    This is the period's biggest negative price driver and a new setback for a core program.

  • June deliveries of 64 jets, 42 of them 737 MAX Boeing handed over 64 planes in June, bringing the first half to 314, and booked 113 net new orders. Airlines pay most of a plane's price on delivery, so rising deliveries turn parked jets into cash and support Boeing's goal of positive free cash flow this year.

    Delivery progress is the clearest new evidence Boeing's cash recovery is on track.

  • FAA nears approval of 737 MAX 7 and MAX 10 engine fix A redesigned engine anti-ice system is in final certification stages, which could clear the MAX 7 and MAX 10 to fly. About 30 MAX 7s and 9 MAX 10s are already built and waiting, and the MAX 10 is over a quarter of Boeing's remaining 737 backlog, so approval unlocks delayed deliveries and cash.

    A pending regulatory green light that would release already-built jets and future revenue.

  • Boeing in advanced talks for ~100-jet SMBC order Boeing is negotiating to sell roughly 100 737 MAX jets to lessor SMBC Aviation Capital, with Airbus chasing a similar A320neo deal ahead of the Farnborough airshow. A win would add to Boeing's backlog and show its best-selling jet still competes for big lessor orders.

    A large potential order that would strengthen demand and the backlog, though talks could still fall through.

▲2▼2

China freighter order, new 737 line lift Boeing; cash burn and Iran risk weigh

  • China Southern's landmark Boeing freighter order China Southern ordered seven Boeing freighters, including five new 777-8Fs, worth $3.6 billion at list prices — the first Boeing order from China in years. It reopens a huge market and signals demand for Boeing's newest cargo jet, supporting future revenue and the stock.

    A major new order from a long-closed market is a genuine demand catalyst for BA.

  • Fourth 737 MAX assembly line starts up Boeing began a fourth 737 MAX line in Everett, part of a plan to reach 52 jets a month by early 2027. More production means more planes delivered and cash coming in, which is central to Boeing's recovery — though it won't lift output before then.

    Added production capacity directly addresses Boeing's core problem of slow deliveries.

  • Weak cash flow and rich valuation vs. Lockheed Boeing burned $1.5 billion in cash in the first quarter and its Commercial Airplanes unit lost $563 million, while it trades at 833 times forward earnings. That contrast with Lockheed's steady cash generation highlights how far Boeing still is from financial health.

    It gives the fair counterweight: Boeing's recovery is real but its finances remain strained.

  • Iran strike threat lifts oil, pressures airlines Trump threatened fresh Iran strikes, pushing oil up 7% and Boeing shares down 3.1%. Higher jet fuel squeezes airline profits, which can delay aircraft orders and deliveries — a reminder that geopolitics can quickly hit demand for Boeing's planes.

    It shows an outside risk that can undercut the positive order and production news.

Q2 2026
▲3▼1

Boeing's defense orders surge, but Airbus and Embraer pressure commercial side

  • Defense order surge and record backlog Boeing's defense unit booked $9 billion in orders, pushing backlog to $86 billion, with strong demand for E-7 Wedgetail and KC-46. This signals steady future revenue and supports the stock by showing a growing, profitable defense business.

    This is a major new positive driver showing Boeing's defense strength and future revenue visibility.

  • New defense contracts add to backlog Boeing won an $880 million Navy training contract, a $2 billion MUOS satellite contract, and smaller deals. These add to the backlog and show Boeing's ability to win high-value defense work, which supports future earnings and the stock price.

    These are new contract wins that directly boost Boeing's order book and future revenue.

  • Airbus and Embraer challenge Boeing's commercial dominance Airbus won a $9.35 billion order from China Eastern, highlighting Boeing's struggle in China. Embraer is also considering a narrow-body jet to challenge the 737. This increases competition and could limit Boeing's future commercial sales and pricing power.

    This is a new competitive threat that could pressure Boeing's commercial business and stock.

  • Quantum satellite milestone advances technology Boeing completed key ground tests for its Q4S quantum networking satellite, set to launch in 2027. This positions Boeing in a new high-tech area for defense and space contracts, potentially opening future revenue streams and supporting the stock.

    This is a new technology milestone that could lead to future contracts and shows Boeing's innovation.

June 2026
▲3▼1

Boeing's defense orders surge, but Airbus and Embraer pressure commercial side

  • Defense order surge and record backlog Boeing's defense unit booked $9 billion in orders, pushing backlog to $86 billion, with strong demand for E-7 Wedgetail and KC-46. This signals steady future revenue and supports the stock by showing a growing, profitable defense business.

    This is a major new positive driver showing Boeing's defense strength and future revenue visibility.

  • New defense contracts add to backlog Boeing won an $880 million Navy training contract, a $2 billion MUOS satellite contract, and smaller deals. These add to the backlog and show Boeing's ability to win high-value defense work, which supports future earnings and the stock price.

    These are new contract wins that directly boost Boeing's order book and future revenue.

  • Airbus and Embraer challenge Boeing's commercial dominance Airbus won a $9.35 billion order from China Eastern, highlighting Boeing's struggle in China. Embraer is also considering a narrow-body jet to challenge the 737. This increases competition and could limit Boeing's future commercial sales and pricing power.

    This is a new competitive threat that could pressure Boeing's commercial business and stock.

  • Quantum satellite milestone advances technology Boeing completed key ground tests for its Q4S quantum networking satellite, set to launch in 2027. This positions Boeing in a new high-tech area for defense and space contracts, potentially opening future revenue streams and supporting the stock.

    This is a new technology milestone that could lead to future contracts and shows Boeing's innovation.

▲3▼1

Boeing's defense orders surge, but Airbus and Embraer pressure commercial side

  • Defense order surge and record backlog Boeing's defense unit booked $9 billion in orders, pushing backlog to $86 billion, with strong demand for E-7 Wedgetail and KC-46. This signals steady future revenue and supports the stock by showing a growing, profitable defense business.

    This is a major new positive driver showing Boeing's defense strength and future revenue visibility.

  • New defense contracts add to backlog Boeing won an $880 million Navy training contract, a $2 billion MUOS satellite contract, and smaller deals. These add to the backlog and show Boeing's ability to win high-value defense work, which supports future earnings and the stock price.

    These are new contract wins that directly boost Boeing's order book and future revenue.

  • Airbus and Embraer challenge Boeing's commercial dominance Airbus won a $9.35 billion order from China Eastern, highlighting Boeing's struggle in China. Embraer is also considering a narrow-body jet to challenge the 737. This increases competition and could limit Boeing's future commercial sales and pricing power.

    This is a new competitive threat that could pressure Boeing's commercial business and stock.

  • Quantum satellite milestone advances technology Boeing completed key ground tests for its Q4S quantum networking satellite, set to launch in 2027. This positions Boeing in a new high-tech area for defense and space contracts, potentially opening future revenue streams and supporting the stock.

    This is a new technology milestone that could lead to future contracts and shows Boeing's innovation.

© 2026 MarketIVWhy